Advertisement

The Journal of Physiological Sciences

, Volume 69, Issue 2, pp 317–326 | Cite as

Application of transcutaneous carbon dioxide improves capillary regression of skeletal muscle in hyperglycemia

  • Tomohiro Matsumoto
  • Masayuki Tanaka
  • Takuya Ikeji
  • Noriaki Maeshige
  • Yoshitada Sakai
  • Toshihiro Akisue
  • Hiroyo Kondo
  • Akihiko Ishihara
  • Hidemi FujinoEmail author
Original Paper
  • 80 Downloads

Abstract

The purpose of the present study was to determine the effects of transcutaneous CO2 application on the blood flow and capillary architecture of the soleus muscle in rats with streptozotocin (STZ)-induced hyperglycemia. Wistar rats were randomly divided into four groups: control, control + CO2-treated, STZ-induced hyperglycemia, and STZ-induced hyperglycemia + CO2-treated groups. Blood flow in soleus muscle increased during the transcutaneous CO2 exposure, and continued to increase for 30 min after the treatment. In addition, the transcutaneous CO2 attenuated a decrease in capillary and the expression level of eNOS and VEGF protein, and an increase in the expression level of MDM-2 and TSP-1 protein of soleus muscle due to STZ-induced hyperglycemia. These results indicate that the application of transcutaneous CO2 could improve capillary regression via the change of pro- and anti-angiogenesis factors, which might be induced by an increase in blood flow.

Keywords

CO2 therapy Diabetes Muscle capillary Blood flow Pro-angiogenesis factors Anti-angiogenesis factors 

Notes

Acknowledgements

The study was supported by Grants-in-Aid for Scientific Research (No. 16H03208) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Author contribution

TM, MT, TI, and HF conceived and designed the experiments. TM, MT and TI performed the experiments. MT, TI and HF analyzed the data. MT, NM, YS, TA, HK, AI and HF contributed by providing regents, materials and analysis tools. TM, MT, TI, HK, AI and HF interpreted the data and wrote the paper. All authors approved the final version of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Slopack D, Roudier E, Liu ST, Nwadozi E, Birot O, Haas TL (2014) Forkhead BoxO transcription factors restrain exercise-induced angiogenesis. J Physiol 592:4069–4082Google Scholar
  2. 2.
    Tanaka M, Kanazashi M, Kondo H, Ishihara A, Fujino H (2018) Protective effects of Brazilian propolis supplementation of capillary regression in the soleus muscle of hindlimb-unloading rats. J Physiol Sci.  https://doi.org/10.1007/s12576-018-0639-z Google Scholar
  3. 3.
    Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P (2002) Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation 106:993–999Google Scholar
  4. 4.
    Thiruvoipati T (2015) Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes 6:961–969Google Scholar
  5. 5.
    Frier BC, Noble EG, Locke M (2008) Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-κB activation and expression. Cell Stress Chaperones 13:287–296Google Scholar
  6. 6.
    Fortes MAS, Pinheiro CHJ, Guimarães-Ferreira L, Vitzel KF, Vasconcelos DAA, Curi R (2015) Overload-induced skeletal muscle hypertrophy is not impaired in STZ-diabetic rats. Physiol Rep.  https://doi.org/10.14814/phy2.12457 Google Scholar
  7. 7.
    Kivelä R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H, Vihko V (2006) Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J 20:1570–1572Google Scholar
  8. 8.
    Kondo H, Fujino H, Murakami S, Nagatomo F, Roy RR, Ishihara A (2011) Regressed three-dimensional capillary network and inhibited angiogenic factors in the soleus muscle of non-obese rats with type 2 diabetes. Nutr Metab.  https://doi.org/10.1186/1743-7075-8-77 Google Scholar
  9. 9.
    Tadaishi M, Miura S, Kai Y, Kano Y, Oishi Y, Ezaki O (2011) Skeletal muscle-specific expression of PGC-1α-b, an exercise-responsive isoform, increases exercise capacity and peak oxygen uptake. PLoS ONE.  https://doi.org/10.1371/journal.pone.0028290 Google Scholar
  10. 10.
    Voltarelli VA, Bacurau AVN, Bechara LRG, Bueno Júnior CR, Bozi LHM, Mattos KC, Salemi VMC, Brum PC (2012) Lack of β2-AR improves exercise capacity and skeletal muscle oxidative phenotype in mice. Scand J Med Sci Sports 22:e125–e132Google Scholar
  11. 11.
    Olfert MI, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL, Wagner PD, Breen EC (2009) Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587:1755–1767Google Scholar
  12. 12.
    Lawler J (2002) Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med.  https://doi.org/10.1111/j.1582-4934.2002.tb00307.x Google Scholar
  13. 13.
    Tang K, Breen EC, Gerber HP, Ferrara NMA, Wagner PD (2004) Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genom 18:63–69Google Scholar
  14. 14.
    Malek MH, Olfert IM (2009) Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp Physiol 94:749–760Google Scholar
  15. 15.
    Malek MH, Olfert IM, Esposito F (2010) Detraining losses of skeletal muscle capillarization are associated with vascular endothelial growth factor protein expression in rats. Exp Physiol 95:359–368Google Scholar
  16. 16.
    Lawler PR, Lawler J (2012) Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2. Cold Spring Harb Perspect Med.  https://doi.org/10.1101/cshperspect.a006627 Google Scholar
  17. 17.
    Smadja DM, D’Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P (2011) Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 31:551–559Google Scholar
  18. 18.
    Roudier E, Milkiewicz M, Birot O, Slopack D, Montelius A, Gustafsson T, Paik JH, Depinho RA, Casale GP, Pipinos II, Haas TL (2013) Endothelial FoxO1 is an intrinsic regulator of thrombospondin 1 expression that restrains angiogenesis in ischemic muscle. Angiogenesis 16:759–772Google Scholar
  19. 19.
    Roudier E, Gineste C, Wazna A, Dehghan K, Desplanches D, Birot O (2010) Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process. J Physiol 588:4579–4591Google Scholar
  20. 20.
    Kanazashi M, Okumura Y, Al-Nassan S, Murakami S, Kondo H, Nagatomo F, Fujita N, Ishihara A, Roy RR, Fujino H (2013) Protective effects of astaxanthin on capillary regression in atrophied soleus muscle of rats. Acta Physiol 207:405–415Google Scholar
  21. 21.
    Hirayama Y, Nakanishi R, Tategaki A, Maeshige N, Kondo H, Ishihara A, Roy RR, Fujino H (2017) Enterococcus faecium strain R30 increases red blood cell velocity and prevents capillary regression in the soleus of hindlimb-unloaded rats via the eNOS/VEGF pathway. Microcirculation.  https://doi.org/10.1111/micc.12356 Google Scholar
  22. 22.
    Kivelä R, Silvennoinen M, Lehti M, Jalava S, Vihko V, Kainulainen H (2008) Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc Diabetol.  https://doi.org/10.1186/1475-2840-7-13 Google Scholar
  23. 23.
    Dunford EC, Leclair E, Aiken J, Mandel ER, Haas TL, Birot O, Riddell MC (2017) The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats. J Appl Physiol 122:492–502Google Scholar
  24. 24.
    Kondo H, Fujino H, Murakami S, Tanaka M, Kanazashi M, Nagatomo F, Ishihara A, Roy RR (2015) Low-intensity running exercise enhances the capillary volume and pro-angiogenic factors in the soleus muscle of type 2 diabetic rats. Muscle Nerve 51:391–399Google Scholar
  25. 25.
    Riggs A (1960) The nature and significance of the Bohr effect in mammalian hemoglobins. J Gen Physiol 43:737–752Google Scholar
  26. 26.
    Goodman M, Moore GW, Matsuda G (1975) Darwinian evolution in the genealogy of haemoglobin. Nature 253:603–608Google Scholar
  27. 27.
    Wells RMG (1999) Evolution of haemoglobin function: molecular adaptations to environment. Clin Exp Pharmacol Physiol 26:591–595Google Scholar
  28. 28.
    Hartmann BR, Bassenge E, Pittler M, Hartmann BR (1997) Effect of carbon dioxide-enriched water and fresh water on the cutaneous microcirculation and oxygen tension in the skin of the foot. Angiology 48:337–343Google Scholar
  29. 29.
    Jensen FB (2004) Red blood cell pH, the Bohr effect, and other oxygenation-linked phenomena in blood O2 and CO2 transport. Acta Physiol Scand 182:215–227Google Scholar
  30. 30.
    Sakai Y, Miwa M, Oe K, Ueha T, Koh A, Niikura T, Iwakura T, Lee SY, Tanaka M, Kurosaka M (2011) A novel system for transcutaneous application of carbon dioxide causing an “artificial Bohr effect” in the human body. PLoS ONE.  https://doi.org/10.1371/journal.pone.0024137 Google Scholar
  31. 31.
    Izumi Y, Yamaguchi T, Yamazaki T, Yamashita N, Nakamura Y, Shiota M, Tanaka M, Sano S, Osada-Oka M, Shimada K, Wanibuchi H, Miura K, Yoshiyama M, Iwao H (2015) Percutaneous carbon dioxide treatment using a gas mist generator enhances the collateral blood flow in the ischemic hindlimb. J Atheroscler Thromb 22:38–51Google Scholar
  32. 32.
    Savin E, Bailliart O, Bonnin P, Bedu M, Cheynel J, Coudert J, Martineaud JP (1995) Vasomotor effects of transcutaneous CO2 in stage II peripheral occlusive arterial disease. Angiology 46:785–791Google Scholar
  33. 33.
    Harrison DG, Sayegh H, Ohara Y, Inoue N, Venema RC (1996) Regulation of expression of the endothelial cell nitric oxide synthase. Clin Exp Pharmacol Physiol 23:251–255Google Scholar
  34. 34.
    Fleming I, Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Integr Comp Physiol 284:R1–R12Google Scholar
  35. 35.
    Baum O, Da Silva-Azevedo L, Willerding G, Wöckel A, Planitzer G, Gossrau R, Pries AR, Zakrzewicz A (2004) Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol 287:H2300–H2308Google Scholar
  36. 36.
    Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242Google Scholar
  37. 37.
    Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342–345Google Scholar
  38. 38.
    Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S (2003) Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285:E123–E129Google Scholar
  39. 39.
    Egginton S (2009) Invited review: activity-induced angiogenesis. Pflugers Arch Eur J Physiol 457:963–977Google Scholar
  40. 40.
    Vassilakopoulos T, Deckman G, Kebbewar M, Rallis G, Harfouche R, Hussain SNA (2003) Regulation of nitric oxide production in limb and ventilatory muscles during chronic exercise training. Am J Physiol Lung Cell Mol Physiol 284:L452–L457Google Scholar
  41. 41.
    Lee-Young RS, Ayala JE, Hunley CF, James FD, Bracy DP, Kang L, Wasserman DH (2010) Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo. AJP Regul Integr Comp Physiol 298:R1399–R1408Google Scholar
  42. 42.
    Irie H, Tatsumi T, Takamiya M, Zen K, Takahashi T, Azuma A, Tateishi K, Nomura T, Hayashi H, Nakajima N, Okigaki M, Matsubara H (2005) Carbon dioxide-rich water bathing enhances collateral blood flow in ischemic hindlimb via mobilization of endothelial progenitor cells and activation of NO-cGMP system. Circulation 111:1523–1529Google Scholar
  43. 43.
    Oe K, Ueha T, Sakai Y, Niikura T, Lee SY, Koh A, Hasegawa T, Tanaka M, Miwa M, Kurosaka M (2011) The effect of transcutaneous application of carbon dioxide (CO2) on skeletal muscle. Biochem Biophys Res Commun 407:148–152Google Scholar
  44. 44.
    Milkiewicz M, Roudier E, Doyle JL, Trifonova A, Birot O, Haas TL (2011) Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle. Am J Pathol 178:935–944Google Scholar
  45. 45.
    Roudier E, Forn P, Perry ME, Birot O (2012) Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle. FASEB J 26:4530–4539Google Scholar
  46. 46.
    Bongrazio M, Da Silva-Azevedo L, Bergmann EC, Baum O, Hinz B, Pries AR, Zakrzewicz A (2006) Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Int J Immunopathol Pharmacol 19:35–48Google Scholar
  47. 47.
    Fujino H (2005) Regression of capillary network in atrophied soleus muscle induced by hindlimb unweighting. J Appl Physiol 98:1407–1413Google Scholar
  48. 48.
    Tanaka M, Kanazashi M, Maezawa T, Kondo H, Fujino H (2015) Abnormalities in three-dimensional capillary architecture and imbalance between vascular endothelial growth factor-A and thrombospondin-1 in soleus muscle of ovariectomized rat. Acta Histochem 117:605–611Google Scholar
  49. 49.
    Rohra DK (2003) Effects of changes in pH on the contractility of vascular smooth muscle. J Coll Physicians Surg Pak 13:544–548Google Scholar
  50. 50.
    Zsother T, Banderman L, Chappel CL (1961) The effects of “local” pH changes on blood flow in the dog. Am Heart J 61:777–782Google Scholar
  51. 51.
    Kellum JA (2000) Determinants of blood pH in health and disease. Crit Care 4(1):6Google Scholar
  52. 52.
    Charter ME, Lamb IR, Murrant CL (2018) Arteriolar and capillary responses to CO2 and H+ in hamster skeletal muscle microvasculature: implications for active hyperemia. Microcirculation.  https://doi.org/10.1111/micc.12493 Google Scholar
  53. 53.
    Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling? In control of vascular function. Nat Rev Mol Cell Biol 7:359–371Google Scholar
  54. 54.
    Wagner PD (2011) The critical role of VEGF in skeletal muscle angiogenesis and blood flow. Biochem Soc Trans 39:1556–1559Google Scholar
  55. 55.
    Delavar H, Nogueira L, Wagner PD, Hogan MC, Metzger D, Breen EC (2014) Skeletal myofiber VEGF is essential for the exercise training response in adult mice. AJP Regul Integr Comp Physiol 306:R586–R595Google Scholar
  56. 56.
    Duling BR (1973) Changes in microvascular diameter and oxygen tension induced by carbon dioxide. Circ Res 32:370–376Google Scholar
  57. 57.
    Graubert MD, Ortega MA, Kessel B, Mortola JF, Iruela-Arispe ML (2001) Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. Am J Pathol 158:1399–1410Google Scholar
  58. 58.
    Greenaway J, Gentry PA, Feige JJ, LaMarre J, Petrik JJ (2005) Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development. Biol Reprod 72:1071–1078Google Scholar
  59. 59.
    Olfert IM, Howlett RA, Wagner PD, Breen EC, Virginia W (2010) Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis. Am J Physiol 299:1059–1067Google Scholar
  60. 60.
    Gorman JL, Liu STK, Slopack D, Shariati K, Hasanee A, Olenich S, Olfert IM, Haas TL (2014) Angiotensin II evokes angiogenic signals within skeletal muscle through co-ordinated effects on skeletal myocytes and endothelial cells. PLoS ONE.  https://doi.org/10.1371/journal.pone.0085537 Google Scholar
  61. 61.
    Uchida C, Nwadozi E, Hasanee A, Olenich S, Olfert IM, Haas TL (2015) Muscle-derived vascular endothelial growth factor regulates microvascular remodelling in response to increased shear stress in mice. Acta Physiol 214:349–360Google Scholar
  62. 62.
    Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691–703Google Scholar
  63. 63.
    Kanazashi M, Tanaka M, Murakami S, Kondo H, Nagatomo F, Ishihara A, Roy RR, Fujino H (2014) Amelioration of capillary regression and atrophy of the soleus muscle in hindlimb-unloaded rats by astaxanthin supplementation and intermittent loading. Exp Physiol 99:1065–1077Google Scholar
  64. 64.
    Olfert IM (2016) Physiological capillary regression is not dependent on reducing VEGF expression. Microcirculation 23:145–156Google Scholar
  65. 65.
    Audet GN, Fulks D, Stricker JC, Olfert IM (2013) Chronic delivery of a thrombospondin-1 mimetic decreases skeletal muscle capillarity in mice. PLoS ONE.  https://doi.org/10.1371/journal.pone0055953 Google Scholar
  66. 66.
    Zhang Y, Liao B, Li M, Cheng M, Fu Y, Liu Q, Chen Q, Liu H, Fang Y, Zhang G, Yu F (2016) Shear stress regulates endothelial cell function through SRB1-eNOS signaling pathway. Cardiovasc Ther 34:308–313Google Scholar
  67. 67.
    Metaxa E, Meng H, Kaluvala SR, Szymanski MP, Paluch RA, Kolega J (2008) Nitric oxide-dependent stimulation of endothelial cell proliferation by sustained high flow. Am J Physiol Heart Circ Physiol 295:H736–H742Google Scholar
  68. 68.
    Shangary S, Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14:5318–5324Google Scholar
  69. 69.
    Hudlicka O, Brown MD, May S, Zakrzewicz A, Pries AR (2006) Changes in capillary shear stress in skeletal muscles exposed to long-term activity: role of nitric oxide. Microcirculation 13:249–259Google Scholar
  70. 70.
    Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlica O, Haas TL (2002) Differential involvement of MMP-2 and VEGF during muscle stretch-versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283:H1430–H1438Google Scholar
  71. 71.
    Hudlicka O, Brown MD (2009) Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res 46:504–512Google Scholar

Copyright information

© The Physiological Society of Japan and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Tomohiro Matsumoto
    • 1
  • Masayuki Tanaka
    • 2
  • Takuya Ikeji
    • 1
  • Noriaki Maeshige
    • 1
  • Yoshitada Sakai
    • 3
  • Toshihiro Akisue
    • 1
  • Hiroyo Kondo
    • 4
  • Akihiko Ishihara
    • 5
  • Hidemi Fujino
    • 1
    Email author
  1. 1.Department of Rehabilitation ScienceKobe University Graduate School of Health SciencesKobeJapan
  2. 2.Department of Physical Therapy, Faculty of Human SciencesOsaka University of Human SciencesSettsuJapan
  3. 3.Division of Rehabilitation MedicineKobe University Graduate School of MedicineKobeJapan
  4. 4.Department of Food Science and NutritionNagoya Women’s UniversityNagoyaJapan
  5. 5.Laboratory of Cell Biology and Life Science, Graduate School of Human and Environmental StudiesKyoto UniversityKyoto-shiJapan

Personalised recommendations